Progerin, an Aberrant Spliced form of Lamin A, is a Potential Therapeutic Target for HGPS

Hutchison-Gilford progeria syndrome (HGPS) is an extremely rare genetic disorder caused by the mutant protein progerin, which is expressed by the abnormal splicing of LMNA gene. HGPS affects systemic levels, except cognition or brain development in children, showing that cellular aging can occur in the short term. However, the causes of aging that humanity is working to overcome remain poorly understood. Studying progeria could be useful for unraveling the causes of human aging (as well as fatal age-related disorders). Elucidating the clear cause of HGPS or the development of a therapeutic medicine will provide inconceivable comfort for young patients and enable them to live a normal life. This review aimed to: i) briefly describe how progerin was discovered as the causative agent of HGPS, ii) elucidate the puzzling observation of the absence of primary neurological disease in HGPS, iii) present several studies showing the deleterious effects of progerin and the beneficial effects of its inhibition, and iv) summarize research to develop a therapy for HGPS, and introduce clinical trials for its treatment..

Medienart:

Preprint

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Preprints.org - (2023) vom: 25. Sept. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

Kim, Bae-Hoon [VerfasserIn]
Chung, Yeon-Ho [VerfasserIn]
Woo, Tae-Gyun [VerfasserIn]
Kang, So-Mi [VerfasserIn]
Park, Soyoung [VerfasserIn]
Park, Bum-Joon [VerfasserIn]

Links:

Volltext [lizenzpflichtig]
Volltext [kostenfrei]

doi:

10.20944/preprints202308.0835.v1

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

preprintsorg040481867